AB.PA
AB Science SA
Price:  
0.69 
EUR
Volume:  
29,121.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-202.5%
Upside

As of 2026-09-29, the EV/EBITDA ratio of AB Science SA (AB.PA) is -11.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 79.46 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -6.75 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.0x - 6.8x 6.1x
Forward P/E multiples 8.7x - 10.1x 9.6x
Fair Price (0.77) - (0.64) (0.71)
Upside -211.1% - -192.3% -202.5%
0.69 EUR
Stock Price
(0.71) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-09-25 -11.70
2026-09-24 -11.82
2026-09-23 -12.06
2026-09-22 -12.09
2026-09-21 -12.12
2026-09-18 -11.99
2026-09-17 -12.09
2026-09-16 -12.05
2026-09-15 -11.96
2026-09-14 -12.20
2026-09-11 -12.34
2026-09-10 -11.99
2026-09-09 -12.01
2026-09-08 -12.37
2026-09-07 -12.27
2026-09-04 -12.37
2026-09-03 -12.40
2026-09-02 -12.48
2026-09-01 -12.43
2026-08-31 -11.96
2026-08-28 -12.24
2026-08-27 -12.24
2026-08-26 -12.10
2026-08-25 -12.47
2026-08-24 -11.53
2026-08-21 -11.82
2026-08-20 -11.82
2026-08-19 -12.05
2026-08-18 -12.09
2026-08-17 -12.19
2026-08-14 -12.54
2026-08-13 -12.20
2026-08-12 -12.36
2026-08-11 -12.92
2026-08-10 -12.57
2026-08-07 -16.13
2026-08-06 -13.41
2026-08-05 -11.95
2026-08-04 -11.19
2026-08-03 -10.69
2026-07-31 -9.69
2026-07-30 -9.55
2026-07-29 -9.91
2026-07-28 -10.08
2026-07-27 -11.89
2026-07-24 -9.27
2026-07-23 -9.45
2026-07-22 -9.93
2026-07-21 -10.10
2026-07-20 -10.01